Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 8,086 | 0.0% | 136,060 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 7,622 | 0.0% | 138,659 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 9,845 | 0.0% | 139,267 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 10,142 | 0.0% | 154,296 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 11,241 | 0.0% | 159,917 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 14,870 | 0.0% | 180,617 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 5,681 | 0.0% | 65,039 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 7,174 | 0.0% | 74,404 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 5,547 | 0.0% | 62,695 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 4,817 | 0.0% | 55,570 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 5,685 | 0.0% | 58,460 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 3,995 | 0.0% | 38,950 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 2,147 | 0.0% | 25,261 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 1,767 | 0.0% | 21,112 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 1,640 | 0.0% | 21,097 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 292 | 0.0% | 3,306 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 290 | 0.0% | 3,758 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 314 | 0.0% | 3,758 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 284 | 0.0% | 3,758 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 330 | 0.0% | 3,758 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 286 | 0.0% | 3,758 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 459 | 0.0% | 3,758 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 360 | 0.0% | 4,256 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 381 | 0.0% | 4,503 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 439 | 0.0% | 6,429 | 3/31/2014 |
| 2013 Q4 | 5/1/2014 | 452 | 0.0% | 6,429 | 12/31/2013 |